Jane Street’s Denali Therapeutics DNLI Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.19M | Sell |
85,332
-128,341
| -60% | -$1.8M | ﹤0.01% | 2661 |
|
2025
Q1 | $2.9M | Sell |
213,673
-15,492
| -7% | -$211K | ﹤0.01% | 1885 |
|
2024
Q4 | $4.67M | Sell |
229,165
-140,506
| -38% | -$2.86M | ﹤0.01% | 1208 |
|
2024
Q3 | $10.8M | Buy |
369,671
+138,307
| +60% | +$4.03M | ﹤0.01% | 716 |
|
2024
Q2 | $5.37M | Buy |
231,364
+182,648
| +375% | +$4.24M | ﹤0.01% | 1614 |
|
2024
Q1 | $1,000K | Sell |
48,716
-100,249
| -67% | -$2.06M | ﹤0.01% | 3208 |
|
2023
Q4 | $3.2M | Buy |
148,965
+110,226
| +285% | +$2.37M | ﹤0.01% | 1958 |
|
2023
Q3 | $799K | Sell |
38,739
-34,061
| -47% | -$703K | ﹤0.01% | 3131 |
|
2023
Q2 | $2.15M | Sell |
72,800
-43,005
| -37% | -$1.27M | ﹤0.01% | 2350 |
|
2023
Q1 | $2.67M | Buy |
115,805
+100,836
| +674% | +$2.32M | ﹤0.01% | 1734 |
|
2022
Q4 | $416K | Buy |
+14,969
| New | +$416K | ﹤0.01% | 3607 |
|
2022
Q3 | – | Sell |
-13,923
| Closed | -$410K | – | 5857 |
|
2022
Q2 | $410K | Buy |
+13,923
| New | +$410K | ﹤0.01% | 3764 |
|
2022
Q1 | – | Sell |
-24,456
| Closed | -$1.09M | – | 5747 |
|
2021
Q4 | $1.09M | Buy |
24,456
+5,759
| +31% | +$257K | ﹤0.01% | 2619 |
|
2021
Q3 | $943K | Buy |
18,697
+14,384
| +334% | +$725K | ﹤0.01% | 2715 |
|
2021
Q2 | $338K | Sell |
4,313
-8,668
| -67% | -$679K | ﹤0.01% | 3848 |
|
2021
Q1 | $741K | Sell |
12,981
-19,613
| -60% | -$1.12M | ﹤0.01% | 2878 |
|
2020
Q4 | $2.73M | Buy |
32,594
+2,748
| +9% | +$230K | ﹤0.01% | 1135 |
|
2020
Q3 | $1.07M | Buy |
29,846
+6,919
| +30% | +$248K | ﹤0.01% | 1737 |
|
2020
Q2 | $554K | Sell |
22,927
-16,039
| -41% | -$388K | ﹤0.01% | 2434 |
|
2020
Q1 | $683K | Buy |
+38,966
| New | +$683K | ﹤0.01% | 1905 |
|
2019
Q4 | – | Sell |
-12,976
| Closed | -$199K | – | 3370 |
|
2019
Q3 | $199K | Buy |
+12,976
| New | +$199K | ﹤0.01% | 3062 |
|
2018
Q4 | – | Sell |
-10,020
| Closed | -$218K | – | 3331 |
|
2018
Q3 | $218K | Buy |
+10,020
| New | +$218K | ﹤0.01% | 3072 |
|